文献速递间质性肺疾病

循环纤维细胞并非特发性肺纤维化的疾病特异性预后指标

Circulating fibrocytes are not disease-specific prognosticators in idiopathic pulmonary fibrosis.
PubMed 文献 · Eur Respir J · 2021-07-22

该研究基于前瞻性队列,评估特发性肺纤维化患者循环纤维细胞水平与预后关系。中位随访3年,循环纤维细胞≥2.2%与死亡风险增加相关,但与疾病相关肺功能下降或短期进展无关。提示其非疾病特异性预后标志物。

要点

  • 循环纤维细胞≥2.2%与特发性肺纤维化患者中位3年随访死亡风险增加相关。
  • 循环纤维细胞水平与疾病相关肺功能下降或短期进展无显著关联。
  • 循环纤维细胞不宜作为特发性肺纤维化的疾病特异性预后指标。

核心结论

  • 循环纤维细胞≥2.2%与特发性肺纤维化患者中位3年随访死亡风险增加相关,但非疾病特异性预后指标。

研究设计与样本

  • 前瞻性队列研究,评估特发性肺纤维化患者循环纤维细胞水平与预后的关系。

主要发现

  • 循环纤维细胞≥2.2%与中位3年随访死亡风险增加相关。
  • 循环纤维细胞水平与疾病相关肺功能下降或短期进展无关。

关键数值与推荐

  • 循环纤维细胞≥2.2%作为观察指标,与特发性肺纤维化患者中位3年随访死亡风险增加相关。

临床怎么用

  • 循环纤维细胞不宜单独用于特发性肺纤维化的疾病特异性预后判断。

局限性

  • 循环纤维细胞在进展性肺纤维化发病机制中的作用尚不明确,临床观察需在前瞻性队列中独立验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In people with idiopathic pulmonary fibrosis, circulating fibrocytes ≥2.2% were associated with a greater risk of mortality over a median 3 years of follow-up, but were not associated with disease-related decline in lung function or short-term progression. https://bit.ly/3bWydwQ A number of previous studies have observed greater levels of circulating fibrocytes in interstitial lung disease compared to healthy controls, and suggest a prognostic role in idiopathic pulmonary fibrosis (IPF) [1–4]. Fibrocytes are circulating mesenchymal progenitor cells that differentiate into tissue specific fibroblasts and contribute to multiple wound healing processes, including secretion of inflammatory cytokines, contractile wound closure and promotion of angiogenesis [5]. However, the contribution of fibrocytes to the pathogenesis of progressive pulmonary fibrosis remains unclear and clinical observations require independent validation in prospective cohorts.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Stewart ID, Nanji H, Figueredo G, et al. Circulating fibrocytes are not disease-specific prognosticators in idiopathic pulmonary fibrosis. Eur Respir J. 2021. PMID: 33766945. doi:10.1183/13993003.00172-2021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。